EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Incidence and Characteristics of Infectious Complications in Multiple Myeloma Patients Treated With Bispecific Antibodies

Taekeun Park iD, Sukjin Jang iD, Youngil Koh iD, Dong-Yeop Shin iD, Sung-Soo Yoon iD, Chan Mi Lee iD, Hyeon Jae Jo iD, Pyoeng Gyun Choe iD, Wan Beom Park iD, Nam Joong Kim iD, Chang Kyung Kang iD, Ja Min Byun iD

Journal of Korean Medical Science · 2025 · 40 (20)

DOI: 10.3346/jkms.2025.40.e86 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Korean Medical Science, 2025. Verfasst von Taekeun Park und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Multiple Myeloma, Antibodies, Bispecific, Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bispecific antibodies (BsAbs) are a new class of immunotherapeutic agents for patients with multiple myeloma (MM). Although this new class of drug is associated with good disease control, they are also associated with increased risk of infectious complications. Since endemic community-acquired and nosocomial infections vary across the globe, we conducted this study to report real-world data of infectious complications associated with BsAbs in Korean population. METHODS: We retrospectively reviewed all MM patients who received BsAb therapy between January 2021 and January 2024 at Seoul National University Hospital. We identified 61 patients who underwent BsAb therapy at our center with median follow-up of 34 weeks (95% confidence interval, 25.85-55.85). Thirty-three patients (54%) received B-cell maturation antigen (BCMA)-targeting BsAb, and 30 (49%) received combination therapy. RESULTS: Of the 61 patients, 39 (64%) had at least one episode of infection. A total of 69 infections affecting patient management occurred during the study period, 3% grade 1 infection, 8% grade 2, 72% grade 3, 8% grade 4 and 8% grade 5. The most common type of infection was lower respiratory tract infection (n = 32/69, 46%), followed by systemic infection (n = 21/69, 30%). Etiology wise, viral infections were most common (67%), followed by fungal infections (13%) and bacterial infections (10%). Among viral infections, cytomegalovirus (CMV) was most common. Patients treated with BCMA-targeting BsAb or combination therapy were associated with higher incidence of CMV reactivation and clinically significant CMV infection. CONCLUSION: Particular pattern of infectious complications including CMV infection was noted in Korean patients. Identifying and determining the nature of infectious disease dynamics is becoming increasingly important for optimal resource allocation and shaping healthcare policies. In this regard, our first-in-Asian population study holds its value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaAntibodies, BispecificInfectionsHumansMaleFemaleMiddle AgedRetrospective StudiesAgedIncidenceAdultAged, 80 and overB-Cell Maturation Antigen

Stichwörter der Autor:innen

Adverse EventsBispecific AntibodiesEpidemiologyInfectionMultiple Myeloma

Substanzen

Antibodies, BispecificB-Cell Maturation Antigen

Autor:innen und Institutionen

  • Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. voyager0@snu.ac.kr.
  • Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea. jaminbyun@snu.ac.kr.

ORCID-Profile: Taekeun Park, Sukjin Jang, Youngil Koh, Dong-Yeop Shin, Sung-Soo Yoon, Chan Mi Lee, Hyeon Jae Jo, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Chang Kyung Kang, Ja Min Byun

Zitieren

APA

Park, T., Jang, S., Koh, Y., Shin, D. Y., Yoon, S. S., Lee, C. M., Jo, H. J., Choe, P. G., Park, W. B., Kim, N. J., Kang, C. K., & Byun, J. M. (2025). Incidence and Characteristics of Infectious Complications in Multiple Myeloma Patients Treated With Bispecific Antibodies. Journal of Korean Medical Science, 40(20). https://doi.org/10.3346/jkms.2025.40.e86

Vancouver

Park T, Jang S, Koh Y, Shin DY, Yoon SS, Lee CM, et al. Incidence and Characteristics of Infectious Complications in Multiple Myeloma Patients Treated With Bispecific Antibodies. Journal of Korean Medical Science. 2025;40(20). doi:10.3346/jkms.2025.40.e86

BibTeX
@article{Park2025,
  author = {Park, Taekeun and Jang, Sukjin and Koh, Youngil and Shin, Dong-Yeop and Yoon, Sung-Soo and Lee, Chan Mi and Jo, Hyeon Jae and Choe, Pyoeng Gyun and Park, Wan Beom and Kim, Nam Joong and Kang, Chang Kyung and Byun, Ja Min},
  title = {Incidence and Characteristics of Infectious Complications in Multiple Myeloma Patients Treated With Bispecific Antibodies},
  journal = {Journal of Korean Medical Science},
  year = {2025},
  volume = {40},
  number = {20},
  doi = {10.3346/jkms.2025.40.e86}
}
Kostenlos starten →